| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63cad7f6f863ee19cd44891dfda05585 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2019-02-08^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1d18730c30881eba528bbeed9d2447d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c5608fd13e162a82236dc395adf7f43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b225c0b52c6462b8d5b9c72b4d3b6045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6c48f1b8d5a61196be3c1eaa5b932e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4542222c85f95ed54fd677d805ea5271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e506282bc892df0ef2f1aa3d7f6c85cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92ac613ddee4f9280d63715dd11d77bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0052f65daa42552e9cee78ba77413dde |
| publicationDate |
2020-11-19^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020361992-A1 |
| titleOfInvention |
Conjugated hepcidin mimetics |
| abstract |
The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472842-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11111272-B2 |
| priorityDate |
2018-02-08^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |